Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 27 of 56
The slide uses peer benchmarking to justify valuation growth expectations based on clinical trial phases.
Pitch deck · peer_benchmark · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 diagram 1/1 source-note 1/1 title 1/1
Components 4
bar-grouped timeline source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1